591 related articles for article (PubMed ID: 15358572)
21. Low plasma protein nitrotyrosine levels distinguish primary Raynaud's phenomenon from scleroderma.
Kingdon EJ; Mani AR; Frost MT; Denton CP; Powis SH; Black CM; Moore KP
Ann Rheum Dis; 2006 Jul; 65(7):952-4. PubMed ID: 16308344
[TBL] [Abstract][Full Text] [Related]
22. Pathogenesis of Raynaud's phenomenon.
Herrick AL
Rheumatology (Oxford); 2005 May; 44(5):587-96. PubMed ID: 15741200
[TBL] [Abstract][Full Text] [Related]
23. [Prognostic factors in Raynaud's phenomenon: usefulness of antinuclear antibodies and of periungual capillaroscopy].
Passiu G; Sebastiani GD; Galeazzi M; Tuveri MA; Nicosia PM; Boirivant R
Medicina (Firenze); 1990; 10(4):405-7. PubMed ID: 2099984
[TBL] [Abstract][Full Text] [Related]
24. Time to diagnosis in systemic sclerosis: is sex a factor?
Hudson M; Thombs B; Baron M;
Arthritis Rheum; 2009 Feb; 61(2):274-8. PubMed ID: 19177534
[TBL] [Abstract][Full Text] [Related]
25. [Sarpogrelate hydrochloride for Raynaud's phenomenon of patients with collagen diseases].
Kumagai S; Morinobu A; Ozaki S; Nakao K; Ishida H
Ryumachi; 1998 Jun; 38(3):504-10. PubMed ID: 9721558
[TBL] [Abstract][Full Text] [Related]
26. Increased circulating platelet-leucocyte complexes in patients with primary Raynaud's phenomenon and Raynaud's phenomenon secondary to systemic sclerosis: a comparative study.
Pamuk GE; Turgut B; Pamuk ON; Vural O; Demir M; Cakir N
Blood Coagul Fibrinolysis; 2007 Jun; 18(4):297-302. PubMed ID: 17473568
[TBL] [Abstract][Full Text] [Related]
27. [Raynaud's phenomenon: pathogenesis and prevalence].
Mikulska D
Ann Acad Med Stetin; 2010; 56(1):11-4. PubMed ID: 21427808
[TBL] [Abstract][Full Text] [Related]
28. Can people with Raynaud's phenomenon travel to high altitude?
Luks AM; Grissom CK; Jean D; Swenson ER
Wilderness Environ Med; 2009; 20(2):129-38. PubMed ID: 19594214
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of Raynaud's phenomenon in a healthy Spanish population.
Riera G; Vilardell M; Vaqué J; Fonollosa V; Bermejo B
J Rheumatol; 1993 Jan; 20(1):66-9. PubMed ID: 8441168
[TBL] [Abstract][Full Text] [Related]
30. Raynaud's phenomenon and other features of scleroderma, including pulmonary hypertension.
Wigley FM
Curr Opin Rheumatol; 1996 Nov; 8(6):561-8. PubMed ID: 9018460
[TBL] [Abstract][Full Text] [Related]
31. [Value of karyotype in vascular acrosyndromes].
Coget JM; Croquette-Bulteel F; Merlen F; Benoit M
Phlebologie; 1987; 40(1):37-45. PubMed ID: 3575435
[TBL] [Abstract][Full Text] [Related]
32. Cytogenetic alterations in lymphocytes of Alzheimer's disease and Parkinson's disease patients.
Petrozzi L; Lucetti C; Scarpato R; Gambaccini G; Trippi F; Bernardini S; Del Dotto P; Migliore L; Bonuccelli U
Neurol Sci; 2002 Sep; 23 Suppl 2():S97-8. PubMed ID: 12548361
[TBL] [Abstract][Full Text] [Related]
33. Treatment of Raynaud's phenomenon.
García-Carrasco M; Jiménez-Hernández M; Escárcega RO; Mendoza-Pinto C; Pardo-Santos R; Levy R; Maldonado CG; Chávez GP; Cervera R
Autoimmun Rev; 2008 Oct; 8(1):62-8. PubMed ID: 18692160
[TBL] [Abstract][Full Text] [Related]
34. [Peripheral haemodynamic disturbances of the limbs in Raynaud's phenomenon (author's transl)].
Schmidt C; Royer RJ; Jacquier A; Schmitt J
J Mal Vasc; 1980; 5(3):215-9. PubMed ID: 7462857
[TBL] [Abstract][Full Text] [Related]
35. [Idiopathic and secondary Raynaud's phenomenon. A comparative psychosomatic approach].
Bayle O; Consoli SM; Baudin M; Vayssairat M; Fiessinger JN; Housset E
Presse Med; 1990 Apr; 19(16):741-5. PubMed ID: 2140158
[TBL] [Abstract][Full Text] [Related]
36. Transition from primary Raynaud's phenomenon to secondary Raynaud's phenomenon identified by diagnosis of an associated disease: results of ten years of prospective surveillance.
Hirschl M; Hirschl K; Lenz M; Katzenschlager R; Hutter HP; Kundi M
Arthritis Rheum; 2006 Jun; 54(6):1974-81. PubMed ID: 16732585
[TBL] [Abstract][Full Text] [Related]
37. Reactive hyperemia in Raynaud's disease.
Pratesi F; Corsi C; Deidda C; Nuti A
Biochem Exp Biol; 1977; 13(3):337-9. PubMed ID: 16296018
[TBL] [Abstract][Full Text] [Related]
38. Raynaud's phenomenon and Raynaud's disease definition of Raynaud's phenomenon.
Pratesi F; Corsi C; Deidda C; Nuti A
Schweiz Rundsch Med Prax; 1976 Nov; 65(44):1368-70. PubMed ID: 1005332
[No Abstract] [Full Text] [Related]
39. Raynaud's phenomenon and thyroid deficiency.
Shagan BP; Friedman SA
Arch Intern Med; 1980 Jun; 140(6):832-3. PubMed ID: 7387277
[TBL] [Abstract][Full Text] [Related]
40. Cooling-induced contraction and protein tyrosine kinase activity of isolated arterioles in secondary Raynaud's phenomenon.
Furspan PB; Chatterjee S; Mayes MD; Freedman RR
Rheumatology (Oxford); 2005 Apr; 44(4):488-94. PubMed ID: 15695304
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
